A dual-peptide compound studied across somatotropic, pituitary, and growth hormone secretagogue signaling pathways. CJC-1295 No DAC and Ipamorelin are investigated for their combined role in GHRH receptor binding, and synergistic short-acting GH pulse amplification mechanisms. Supplied as a lyophilized powder, manufactured under controlled conditions, and quality tested. Certificate of analysis documentation included with every batch.
Vial Size
A synthetic analog of growth hormone-releasing hormone studied across somatotropic, hypothalamic, and pituitary signaling pathways. Sermorelin is investigated for its role in GHRH receptor binding, GH pulse stimulation, and growth hormone axis modulation mechanisms. Supplied as a lyophilized powder, manufactured under controlled conditions, and quality tested before release. Certificate of analysis documentation included with every batch.
Vial Size
A research-grade lyophilized peptide blend containing Tesamorelin, a synthetic GHRH analog, and Ipamorelin, a selective growth hormone secretagogue. Both compounds have been the subject of extensive peer-reviewed scientific literature and are among the most widely referenced peptides in contemporary research settings. Each batch is third-party tested and supplied with a Certificate of Analysis for laboratory research purposes only. Not for human or veterinary use.
Vial Size
All compounds are manufactured for research and analytical purposes only. Not intended for human consumption, diagnostic use, or therapeutic application. Professional verification required for purchase.
Discount Applied Successfully!
Your savings have been added to the cart.
